Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

AMRめぐる課題、パートナーシップで取り組み―塩野義などと提携のGARDP「アクセス改善と新薬開発に注力」

10 December 2024

Answer Newslogo

 

10 December 2024

世界で毎年100万人以上の命を奪っている薬剤耐性(AMR)菌感染症。その死者はHIVやマラリアといったほかの感染症を上回り、公衆衛生にとって大きな脅威となっているにもかかわらず、収益性が低く新薬開発を行う企業は少なく、途上国を中心に治療薬が行き渡っていません。

こうした課題の改善に独自のパートナーシップモデルで取り組むのが、スイス・ジュネーブに本部を置く非営利団体Global Antibiotic Research and Development Partnership(GARDP、グローバル抗菌薬研究開発パートナーシップ)です。来日したR&Dディレクターのシェイマス・オブライアン氏と、ビジネスディベロップメント&パートナーシップ・エンゲージメント ディレクターのヤン・フェリス氏に、活動について聞きました。